Synmosa Biopharma Corp - ESG Rating & Company Profile powered by AI
The report of Synmosa Biopharma Corp uses data from across the internet as well as from available disclosures by Synmosa Biopharma Corp. Scroll down to the bottom of the webpage for potential risks for Synmosa Biopharma Corp based on industry, location and size. Alternative corporations in the rating industry group for Synmosa Biopharma Corp are displayed.
Synmosa Biopharma Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Synmosa Biopharma Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Synmosa Biopharma Corp have an accelerator or VC vehicle to help deliver innovation?
Does Synmosa Biopharma Corp disclose current and historical energy intensity?
Does Synmosa Biopharma Corp report the average age of the workforce?
Does Synmosa Biopharma Corp reference operational or capital allocation in relation to climate change?
Does Synmosa Biopharma Corp disclose its ethnicity pay gap?
Does Synmosa Biopharma Corp disclose cybersecurity risks?
Does Synmosa Biopharma Corp offer flexible work?
Does Synmosa Biopharma Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Synmosa Biopharma Corp disclose the number of employees in R&D functions?
Does Synmosa Biopharma Corp conduct supply chain audits?
Does Synmosa Biopharma Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Synmosa Biopharma Corp conduct 360 degree staff reviews?
Does Synmosa Biopharma Corp disclose the individual responsible for D&I?
Does Synmosa Biopharma Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Synmosa Biopharma Corp disclose current and / or historical scope 2 emissions?
Does Synmosa Biopharma Corp disclose water use targets?
Does Synmosa Biopharma Corp have careers partnerships with academic institutions?
Did Synmosa Biopharma Corp have a product recall in the last two years?
Does Synmosa Biopharma Corp disclose incidents of discrimination?
Does Synmosa Biopharma Corp allow for Work Councils/Collective Agreements to be formed?
Has Synmosa Biopharma Corp issued a profit warning in the past 24 months?
Does Synmosa Biopharma Corp disclose parental leave metrics?
Does Synmosa Biopharma Corp disclose climate scenario or pathway analysis?
Does Synmosa Biopharma Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Synmosa Biopharma Corp disclose the pay ratio of women to men?
Does Synmosa Biopharma Corp support suppliers with sustainability related research and development?
Does Synmosa Biopharma Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Synmosa Biopharma Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Synmosa Biopharma Corp involved in embryonic stem cell research?
Does Synmosa Biopharma Corp disclose GHG and Air Emissions intensity?
Does Synmosa Biopharma Corp disclose its waste policy?
Does Synmosa Biopharma Corp report according to TCFD requirements?
Does Synmosa Biopharma Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Synmosa Biopharma Corp disclose energy use targets?
Does Synmosa Biopharma Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Synmosa Biopharma Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Synmosa Biopharma Corp
These potential risks are based on the size, segment and geographies of the company.
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, and other forms. It also offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei City, Taiwan.